TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues. May 5, 2006
TCL Archive President’s FY 1992 Budget Seeks $1.81 Billion For NCI, 5.6% Increase, But $800M Below Byspass February 8, 1991
